Article Details
Retrieved on: 2024-04-05 21:56:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses NeuroVigil's successful Series B financing for its non-invasive iBrain device, which is being used to detect biomarkers for various brain conditions and may impact battery management for electric vehicles. Notably, it mentions partnerships with Novartis and involvement from Philip Low.
Article found on: www.globenewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here